Bioavailability of oxytetracycline from medicated feed administered to Atlantic salmon (Salmo salar L.) in seawater

Bioavailability of oxytetracycline HCl was investigated in Atlantic salmon (Salmo salar L.) in seawater at 7–8 °C. A group of 80 fish received an intravascular injection of 20 mg kg⁻¹ body weight. Another group of about 90 fish were force-fed with medicated feed containing a dose of 50 mg kg⁻¹ body weight. The oral bioavailability was found to be only 2%.     

Astaxanthin deposition in the flesh of Atlantic Salmon, Salmo salar L., in relation to dietary astaxanthin concentration and feeding period

Atlantic salmon, Salmo salar L., were fed nine experimental diets containing from 0 to 200 mg astaxanthin per kg^?1 for six time periods, ranging from 3 to 21 months, in sea cages at Matre Aquaculture Research Station, Matredal, Norway. The sampled fish had an initial mean weight of 115 g and reached a weight of 3.2 kg at the termination of the experiment. Every third month, 10 fish from each dose and time group were sampled and the astaxanthin concentration in the flesh determined. The amount of astaxanthin in the flesh ranged from 0.7 to 8.9 mg kg^?1 at the termination of the experiment. This paper discusses deposition of astaxanthin in the flesh of Atlantic salmon in relation to dietary carotenoid levels in the 0–200 mg kg^?1 range and feeding times of 3–21 months. Under the conditions of this experiment, no significant effect on astaxanthin deposition rate could be achieved by increasing the astaxanthin level above 60 mg kg dry feed^?1. Atlantic salmon should be fed astaxanthin-supplemented diets during the whole seawater stage in order to obtain maximal astaxanthin level in the flesh.     

Growth and survival of Atlantic salmon, Salmo salar L. fed different dietary levels of astaxanthin. Juveniles

Atlantic salmon, Salmo salar L., juveniles, with a mean initial weight of 1.75 g, were fed casein-based purified diets which had been supplemented with different levels of astaxanthin for a 10-week period. The astaxanthin content of the diets ranged from 0 to 190 mg kg^?1 dry diet. The growth and survival of the juveniles were recorded throughout the experiment. The proximate composition, astaxanthin and vitamin A content were determined from whole-body samples at the start and termination of the experiment. The dietary treatment was found to affect growth significantly (P < 0.05). A reduction in the mean weight of the juveniles was observed in the groups fed the diets without astaxanthin supplementation. There was no difference in growth rate between the fish in the groups fed the diets containing 36 or 190 mg astaxanthin kg^?1 dry diet, whereas the fish in the group fed the diet containing 5.3 mg astaxanthin kg^?1 dry diet had a lower growth rate. There was a tendency to higher survival in the groups fed the diets containing astaxanthin when compared with the groups fed the non-supplemented diets. The moisture and ash contents were significantly lower and the lipid content was higher in the groups fed the astaxanthin-supplemented diets. The astaxanthin and the vitamin A concentrations in the fish were found to be dependent upon the dietary astaxanthin dose; the highest values were found in the fish fed the diet with the highest astaxanthin content. These results strongly indicate that astaxanthin functions as a provitamin A for juvenile Atlantic salmon. The body storage of vitamin A increased in the fish fed the diets containing astaxanthin. However, the increase was low in the fish fed the diet containing 5.3 mg astaxanthin kg^?1 dry diet.     

Astaxanthin deposition in fillets of Atlantic salmon Salmo salar L. fed two dietary levels of astaxanthin in combination with three levels of α-tocopheryl acetate

The influence of α-tocopheryl acetate (α-TOAc) on plasma concentration and fillet deposition of dietary astaxanthin was investigated in Atlantic salmon Salmo salar L. The diets were added 30 or 50 mg kg^–1 astaxanthin, and 200, 400 or 800 mg kg^–1α-TOAc at each astaxanthin level. Improved flesh deposition of astaxanthin by 8–14% was achieved for fish fed diets with 30 and 50 mg kg^–1 astaxanthin, respectively, by the dietary addition of 800 compared with 200 mg kg^–1α-TOAc. These results were supported by CIE[1976]L*a*b* tristimulus redness measurements (a* value). Plasma astaxanthin concentration mirrored the muscle astaxanthin concentration in the groups of fish fed a diet containing 30 mg kg^–1 astaxanthin. The salmon fed a high astaxanthin and low α-TOAc diet had the highest plasma concentration of idoxanthin (P < 0.05). Astaxanthin retention was significantly higher (P < 0.001) in salmon fed 30 mg kg^–1 astaxanthin than in those fed 50 mg kg^–1 astaxanthin, but was not significantly affected by dietary α-TOAc. Liver weight, body weight, specific growth rate, feed/gain ratio and mortalities were not affected by dietary α-TOAc levels. In conclusion, the dietary addition of α-TOAc appears to increase astaxanthin fillet deposition in salmonids and may reduce the demand for astaxanthin supplementation. The effect was rather small and requires verification.     

Effects of dietary protein, and fat level and rapeseed oil on growth and tissue fatty acid composition and metabolism in Atlantic salmon (Salmo salar L.) reared at low water temperatures

A 12‐week feeding trial was conducted to elucidate the interactive effects of dietary fat, protein contents and oil source on growth, whole body proximate composition, protein productive value (PPV) and fatty acid (FA) composition of muscle and liver in Atlantic salmon (Salmo salar L.)` at low water temperatures (4.2 °C). Triplicate groups of Atlantic salmon (initial weight 1168 g) were fed six isoenergetic diets, formulated to provide either 390 g kg⁻¹ protein and 320 g kg⁻¹ fat (high‐protein diets) or 340 g kg⁻¹ protein and 360 g kg⁻¹ fat (low‐protein diets). Within each dietary protein/fat level, crude rapeseed oil (RO) comprised 0, 30 or 60% (R0, R30, R60, respectively) of the added oil. After 12 weeks, the overall growth and feed conversion ratio (FCR) were very good for all treatments [thermal growth coefficient (TGC): 4.76 (±0.23); FCR: 0.85 (±0.02)]. Significant effects were shown owing to the oil source on specific growth rate and TGC only. The liver and muscle FA compositions were highly affected by the graded inclusion of RO. The PPV was significantly affected by the dietary protein level. The results of this study suggest that more sustainable, lower protein diets with moderate RO inclusion can be used in Atlantic salmon culture at low water temperatures with no negative effects on growth and feed conversion, no major detrimental effects on lipid and FA metabolism and a positive effect on protein sparing.     

A single-dose pharmacokinetic study of oxolinic acid and vetoquinol, an oxolinic acid ester, in Atlantic halibut, Hippoglossus hippoglossus L., held in sea water at 9 °C

The pharmacokinetic properties of the antibacterial agent oxolinic acid were studied after intravenous, intraperitoneal and oral administration to 1.5–3.0 kg Atlantic halibut, Hippoglossus hippoglossus L., held in sea water at 9 °C. Following intravenous injection, the plasma drug concentration-time profile showed two distinct phases. The terminal elimination half-life was estimated to be 52 h, whereas total body clearance (Cl_T) was determined to be 0.044 L kg^–1 h^–1. The volume of distribution at steady state, V_d(ss), was calculated to be 3.0 L kg^–1, indicating good tissue penetration of oxolinic acid in Atlantic halibut. The peak plasma concentration (C_max) and the time to peak plasma concentration (T_max) were estimated to be 1.2 and 2.7 μg mL^–1, and 21.5 and 80 h, respectively, following oral administration of medicated feed or intraperitoneal injection. The corresponding bioavailabilities were calculated to be 15% and 92%, respectively. Oral administration of vetoquinol, the carbitol ester of oxolinic acid, increased the bioavailability of oxolinic acid to 64% and the total bioavailability (oxolinic acid + vetoquinol) to 82%, whereas C_max and T_max values of 6.7 μg mL^–1 and 14.5 h, respectively, for oxolinic acid, and 1.0 μg mL^–1 and 6.3 h, respectively, for vetoquinol were obtained. Based on a minimum inhibitory concentration (MIC) of 0.0625 μg mL^–1 for susceptible strains, a single intraperitoneal injection of 25 mg kg^–1 of oxolinic acid maintains plasma levels in excess of 0.25 μg mL^–1, corresponding to four times the MIC value, for ≈12 days. The corresponding values for a single oral dose of 25 mg kg^–1 of oxolinic acid and vetoquinol were 5 and 10 days, respectively. For resistant strains with a MIC of 1 μg mL^–1, a single oral dose of vetoquinol (25 mg kg^–1) maintained plasma levels in excess of 4 μg mL^–1 for 34 h.     

Growth and survival of Atlantic salmon, Salmo salar L., fed different dietary levels of astaxanthin. First-feeding fry

Atlantic salmon fry hatched from pigment-free eggs and from eggs containing the pigment astaxanthin were fed eleven casein/gelatine-based purified diets with varying levels of astaxanthin, ranging from 0 to 317 mg kg^?1, to determine the optimum dietary astaxanthin level for satisfactory growth and survival during the start-feeding period. The fish were fed the experimental diets for a period of 11 weeks. No difference in performance was found between the two types of fry originating from the pigment-free eggs and those containing pigment. However, the dietary astaxanthin concentration was found to have a significant effect on both the growth and the survival of fry. Fish fed diets with astaxanthin concentrations below 5.3 mg kg^?1 were found to have marginal growth. In addition, mortality was high in the groups fed diets with astaxanthin concentrations below 1.0 mg kg^?1. The specific growth rate (SGR) was also affected by the dietary treatment. The lipid content was higher and the moisture content was lower in the fish fed the diets containing astaxanthin concentrations above 5.3 mg kg^?1. The vitamin A and astaxanthin concentrations in whole-body samples of the fry were significantly affected by the dietary level of astaxanthin. A plateau level in whole-body vitamin A concentration was observed at dietary levels of approximately 80 mg astaxanthin kg^?1 and higher, while no maximum astaxanthin concentration in whole-body samples was observed within the dietary levels used. The results suggest the need for a minimum dietary astaxanthin concentration of 5.1 mg kg^?1 to achieve maximum growth and survival during the start-feeding period. The results indicate a low bioavailability of vitamin A palmitate and acetate and the results also suggest a provitamin A function for astaxanthin during the same period.     

Dietary phosphorus does not reduce the risk for spinal deformities in a model of adjuvant‐induced inflammation in Atlantic salmon (Salmo salar) postsmolts

Inflammation is a non‐specific protective mechanism towards injury known to affect bone remodelling. This study aimed to investigate the effect of Freund’s complete adjuvant (FCA) induced‐inflammation on the prevalence of spinal deformities of Atlantic salmon postsmolts fed with two different dietary P levels. Sextuple groups of salmon postsmolts were fed with either a low‐phosphorous (6 g kg^?1 available P, LP) or a high‐phosphorous (9 g kg^?1 available P) diet for a period of 101 days. On Day 102, individually tagged fish were subjected to (i) single injection with FCA (0.125 mg kg^?1 BW) dissolved in phosphate‐buffered saline (PBS) (ii) placebo injection with PBS or (iii) sham injection (insertion of needle only) or (iv) remained untreated. On Day 103, fish were given a common diet for 174 days in seawater. No significant differences in body weight were observed. Injected fish, particularly the FCA group, had more compressions in the injection site than untreated fish. No effect of diet and no interaction between treatment and diet were observed. Severe scoliosis was observed in ～7% of FCA‐injected individuals, corresponding to a mixture of bone malformations in the tail region. In conclusion, experimentally induced inflammation may be an independent risk factor for bone deformities in Atlantic salmon.     

Antioxidant vitamins, minerals and lipid levels in diets for Atlantic salmon (Salmo salar, L.): effects on growth performance and fillet quality

An experiment with 2^{(7 ? 3)} reduced factorial design was conducted to study the biological effects of pro‐ and antioxidant micronutrients and lipid in Atlantic salmon. Vitamins C and E, astaxanthin, lipid, iron, copper and manganese were supplemented at high and low levels. For vitamins and minerals, high levels were chosen to be below the anticipated toxic level and the low levels were just above the requirement (vitamin C, 30 and 1000 mg kg^?1; vitamin E, 70 and 430 mg kg^?1; Fe, 70 and 1200 mg kg^?1; Cu, 8 and 110 mg kg^?1; Mn, 12 and 200 mg kg^?1). For astaxanthin, the dietary levels were 10 and 50 mg kg^?1 and for lipid, 150 and 330 g kg^?1. The experiment was started with postsmolts (148 ± 17 g) and lasted for 5 months. The variation in micronutrients had only minor effects on growth, feed conversion and fillet quality, measured as lipid and astaxanthin deposition. High dietary lipid had a profound positive effect on growth and feed conversion but gave fillets nearly two times the fat content that was found in fish fed the low lipid diet. Astaxanthin deposition in the fillet was primarily affected by dietary astaxanthin with a positive effect of high dietary lipid in week 14 but not in week 23. Vitamin E protected the fillet against iron ascorbate stimulated oxidation, with no effect of the other nutrient variables.     

How Apparent Digestibility of Carotenoids,Macronutrients, and Minerals are Differently Affected by Ration Level in Atlantic Salmon,Salmo Salar

The main objective of this field experiment was to investigate whether ration level affected utilization of carotenoids, macronutrients, and minerals in 1,300 g Atlantic salmon (Salmo salar) during rapid growth. Salmon fed ration levels of either 1.2% or 0.6% of biomass of a commercial diet supplemented with astaxanthin and canthaxanthin (37 and 39 mg kg^?1, respectively) in two consecutive 6-day feeding periods had carotenoid digestibility coefficients of 11.8% and 32.1% at the high and low feed rations, respectively. Thus, low carotenoid digestibility, but good macronutrient digestibility, may explain poor pigmentation and good feed conversion in rapidly growing salmon. Practical implications are illustrated.     

Pharmacokinetics and bioavailabilities of 14C-keto-carotenoids, astaxanthin and canthaxanthin, in rainbow trout, Oncorhynchus mykiss

The pharmacokinetics and bioavailabilities of ¹⁴C‐astaxanthin and ¹⁴C‐canthaxanthin were studied in the blood of rainbow trout following intra‐arterial (i.a.) and oral (p.o.) administration. Sixteen months old 1 kg trout were cannulated in the dorsal aorta. [6,7,6′,7′‐¹⁴C]‐keto‐carotenoids were administered i.a. and p.o. at a dose of 573.5 kBq kg^?1 fish body weight for astaxanthin and 836.2 kBq kg^?1 fish body weight for canthaxanthin. After i.a. distribution, total body clearance (Cl_tot) was 17.30±20.29 mL kg^?1 of fish h^?1 for ¹⁴C‐canthaxanthin and 3.30±1.50 mL kg^?1 of fish h^?1 for ¹⁴C‐astaxanthin. The volume of distribution at steady‐state (V_ss) was 208.32±124.79 mL kg^?1 of fish and 71.84±64.15 mL kg^?1 of fish for ¹⁴C‐canthaxanthin and ¹⁴C‐astaxanthin respectively. Less than 0.4% of the administered radioactivity was recovered in urine. Radioactivity (expressed as percent of the dose) excreted in the bile of fish that received ¹⁴C‐canthaxanthin by i.a. route was 20‐fold higher than that observed for fish treated p.o. This ratio was lower for ¹⁴C‐astaxanthin (7.6‐fold). The mean keto‐carotenoid bioavailabilities calculated were 10–15% for both compounds. Findings suggest one daily astaxanthin application is preferable, while 12‐h time intervals between applications are preferable for canthaxanthin.     

Pharmacokinetics of oxolinic acid in black tiger shrimp, Penaeus monodon Fabricius, and the effect of cooking on residues

This study examined the pharmacokinetics and bioavailability of oxolinic acid (OA) in black tiger shrimp Penaeus monodon Fabricius, in brackish water (salinity 10 g L^?1) at 28–29°C, after intra‐sinus (10 mg kg^?1) and oral (50 mg kg^?1) administration and also investigated the net changes of OA residues in the shrimp after cooking (boiling, baking and frying). The haemolymph concentrations of OA after intra‐sinus dosing were best described by a two‐compartment open model. The distribution and elimination half‐lives were 0.84 and 17.7 h respectively. The apparent volume of distribution at a steady state and the total body clearance were estimated to be 2061 mL kg^?1 and 90.1 mL kg^?1 h^?1 respectively. The bioavailability of OA after an oral administration was 7.9%. The peak haemolymph concentration, the time to peak haemolymph concentration and the elimination half‐life after oral administration were 4.20 μg mL^?1, 4 h and 19.8 h respectively. Oxolinic acid muscle and shell levels increased to a maximum (muscle 1.76 μg g^?1 and shell 8.17 μg g^?1) at 4 h post administration and then decreased with the elimination half‐life value of 20.2 and 21.9 h respectively. Residual OA in muscle and shell was reduced by 20–30% by each cooking procedure examined.     

Dorsal aorta cannulation: a method to monitor changes in blood levels of astaxanthin in voluntarily feeding Atlantic salmon, Salmo salar L.

This study was undertaken to assess dorsal aorta cannulation as a method to evaluate alterations in diet composition and feeding protocol on pigment retention in salmonid fish. Temporal changes in blood astaxanthin concentrations of dorsal aortacannulated Atlantic salmon, Salmo salar L., were followed in relation to variations in dietary pigment concentration and fish-feeding husbandry protocol. The fish were held individually in 200-L fibreglass tanks supplied with running sea water. Each fish was forced to swim at 0.5 body lengths s^?1 and was fed daily by hand to satiation. The fish had an average growth rate of 1% day^?1. Blood astaxanthin concentrations were noted to be highly correlated (r= 0.995) with dietary levels of astaxanthin, but not as well correlated (r= 0.71) with total gut content of this pigment. Marked variations in blood astaxanthin concentration were noted between individual fish at each dietary pigment concentration, but the ranking of the fish was generally unaffected between each dietary pigment level. After cessation of feeding a diet supplemented with 75 mg of astaxanthin kg^?1, salmon fed a diet with no pigment showed more-rapid blood pigment clearance than those that were starved. Likely, feed remaining in the alimentary tract of the starved fish functioned as a reservoir of pigment for the blood until the intestinal tract was empty. Blood pigment levels were not depressed in salmon fed a diet supplemented with 75 mg of astaxanthin kg^?1 once daily instead of twice daily.     

Broodstock diet with water and astaxanthin improve condition and egg output of brood fish and larval survival in Atlantic cod,Gadus morhua L.

Broodstock of Atlantic cod were fed with three diets; astaxanthin supplemented (100 ppm kg^?1) hydrated diet (30% water) (HWHAs), no additional astaxanthin supplemented (50 ppm kg^?1) hydrated diet (30% water) (HWLAs) and a control diet (50 ppm kg^?1 astaxanthin and 10% water). Throughout the spawning period, eggs were collected daily and fertilization success and proportion of embryos with normal cleavage were recorded. Larvae were reared using standard culture methods. Larval growth was recorded every 10 days and larval survival was recorded at 50 days post hatch. In general, broodstock fed with diets containing higher water content (HWHAs and HWLAs) and higher astaxanthin (HWHAs) had higher egg production and efficiency of egg output, lower egg incubation mortality and higher larval growth and survival. Broodstock fed with higher water content diets consumed less feed compared to control group. Also, broodstock fed with HWHAs and HWLAs recovered faster in terms of body condition than the control group. The egg bound mortality of female fish was significantly higher in control broodstock compared to broodstock fed with HWHAs and HWLAs. Broodstock fed with higher astaxanthin (HWHAs) had significantly higher fertilization success than other two groups however; no differences were found in proportion embryos with normal cleavage among different groups. Larval survival was significantly higher in HWHAs broodstock compared to other two groups. Our results showed that increased water content and astaxanthin levels in the diet could improve the condition and fecundity of Atlantic cod broodstock.     

The effect of feed pigment type on flesh pigment deposition and colour in farmed Atlantic salmon, Salmo salar L.

The characteristic pink colour of salmonid flesh is a result of deposition of naturally occurring carotenoid pigments. Achieving successful pigmentation in farmed salmonids is a vital aspect of fish farming and commercial feed production. Currently commercial diets for farmed salmonids contain either or both of the synthetic pigments commercially available, astaxanthin and canthaxanthin. Atlantic salmon, Salmo salar L. ( = 220 g initial weight) were given feeds where the pigment source was astaxanthin only, canthaxanthin only or a astaxanthin/canthaxanthin mix. The rearing environment was 12 × 3 m tanks supplied with sea water at the EWOS research farm Lønningdal, near Bergen, Norway. As the proportion of dietary canthaxanthin increased, flesh pigment levels also showed an increase; the pigment content in the muscle of canthaxanthin‐only fed fish was 0.4 mg kg^?1 (or 14%) higher than that of the astaxanthin‐only fed fish, with the mixed pigment fed fish being intermediate between the two extremes. Results of cross‐section assessment for Minolta colorimeter redness (a*) values and Roche Salmofan^TM scores also showed an increase in colour with increasing proportions of canthaxanthin in the feed. The data reported clearly indicates that S. salar ( = 810 g final weight) of this size deposit canthaxanthin more efficiently than they do astaxanthin. These results contrast with those obtained by other authors with rainbow trout, Oncorynchus mykiss (Walbaum), and imply that the absorption or utilization of the pigments differs between species.     

Given the same dietary carotenoid inclusion, Atlantic salmon, Salmo salar (L.) display higher blood levels of canthaxanthin than astaxanthin

Atlantic salmon, Salmo salar, fitted with permanent dorsal aorta cannulae were fed diets containing either 0, 30, 60 mg kg^?1 or combinations of astaxanthin and canthaxanthin, with the aim of comparing the uptake efficiencies to blood of the two pigments and evaluating possible interactions during absorption when formulated in the same diet. Given either astaxanthin or canthaxanthin in separate diets, at dietary levels of <30 mg kg^?1, an identical linear relationship (R² = 0.97) between dietary levels and blood concentrations was observed for both carotenoids. At dietary astaxanthin inclusions above 30 mg kg^?1, blood astaxanthin concentration approached saturation at an average level of 1.2 ± 0.04 μg mL^?1 (arithmetic mean ± SD), whereas blood levels of canthaxanthin continued to increase linearly throughout the inclusion range tested (0–60 mg kg^?1). When both carotenoids were presented in the same diet, a reduction in the absorption efficiency of both pigments was observed (P < 0.05). This manifested itself as a lower level in blood than the level observed when each carotenoid was administered separately. The negative interaction was most prominent for astaxanthin, the maximum average blood saturation level of which fell (P < 0.05) to 0.73 ± 0.03 μg mL^?1 (arithmetic mean ± SD). Our data support the conclusion that at higher dietary inclusions, canthaxanthin is more efficiently absorbed from the digestive tract into the blood of S. salar than astaxanthin.     

Drinking rate in juvenile Atlantic salmon,Salmo salar L fry in response to a nitric oxide donor,sodium nitroprusside and an inhibitor of angiotensin converting enzyme,enalapril

Drinking in freshwater juvenile salmon was investigated in response to vasodilation by sodium nitroprusside (SNP), a nitric oxide donor, which significantly increased blood vessel diameter in Atlantic salmon alevins. Atlantic salmon fry (1–3 g), as previously shown, drank at a significant rate in fresh water which doubled to about 1.2 ml kg^–1 h^–1 following injection of SNP (100 mol kg^–1), through dilation of body vasculature and activation of a vasoconstrictive mechanism, the endogenous renin angiotensin system (RAS). This response was 50% inhibited by injection of about 100 mg kg^–1 enalapril. Fry increased drinking in response to SNP administered in the water, though the concentration required for maximal response, 1.6 mmol l^–1, was much greater than for injected SNP; this response was also inhibited by enalapril injection. Possible involvement of the gill vasculature and branchial osmoreceptors or baroreceptors in control of the drinking response is discussed.     

Energy and nutrient utilization of Atlantic cod, Atlantic salmon and rainbow trout fed diets differing in energy content

The growth and feed utilization of Atlantic cod (Gadus morhua) (437 g), Atlantic salmon (Salmo salar) (485 g) and rainbow trout (Oncorhynchus mykiss) (413 g) fed a diet (170 g kg⁻¹ fat, 600 g kg⁻¹ crude protein; LE) similar to that used in commercial cod production or one that was top dressed with additional fat (280 g kg⁻¹ fat, 530 g kg⁻¹ crude protein; HE), were compared in an 11‐week trial. In the cod, relative feed intake was 41–58% and thermal growth coefficient 63% of that in the salmonids, but the feed efficiency ratio (FER) was 38% better (P ≤ 0.05). In contrast to the cod where there was no effect of diet on feed intake, growth or FER, both the salmon and trout fed the HE diet had greater feed intake than those fed the LE diet, but the effect of this was only positive for growth in the salmon. The cod retained more of the digested nitrogen (44.9 ± 2.7%) than the salmon (39.4 ± 0.8%), and both of these species retained more than the trout (33.6 ± 1.1%) (P ≤ 0.05). The retention of digested energy was significantly higher in the salmon (52.2 ± 0.9%) than in the trout (44.8 ± 1.1%), with the cod (44.9 ± 4.9%) not different from either of the other species. There were no differences between the species in the retention of absorbed phosphorus (65.9 ± 3.6%). There were very few dietary effects on nutrient utilization in this trial and, for the cod, this indicates that higher energy diets may be feasible for use in production.     

Efficacy of an equal blend of canola oil and poultry fat as an alternate dietary lipid source for Atlantic salmon (Salmo salar L.) in sea water. I: effects on growth performance, and whole body and fillet proximate and lipid composition

This study assessed the suitability and cost efficacy of an equal blend of canola oil (CO) and poultry fat (PF) as a supplemental dietary lipid source for juvenile Atlantic salmon. Quadruplicate groups of Atlantic salmon (～400 g) held in 4000 L outdoor fibreglass tanks supplied with running (35–40 L min^?1), aerated (dissolved oxygen, 7.88–10.4 mg L^?1), ambient temperature (8.6–10.9°C) sea water (salinity, 26–35 g L^?1) were fed twice daily to satiation one of three extruded dry pelleted diets of equivalent protein (488–493 g kg^?1 dry matter) and lipid (267–274 g kg^?1 dry matter) content for 84 days. The diets were identical in composition except for the supplemental lipid (234.7 g kg^?1) source viz., 100% anchovy oil (AO; diet COPF‐0), 70.2% AO and 29.8% CO and PF (diet COPF‐30), and 40.3% AO and 59.7% CO and PF (diet COPF‐60). Atlantic salmon growth rate, feed intake, feed efficiency, protein and gross energy utilization, percent survival and whole body and fillet proximate compositions were not affected by diet treatment. Cost per kilogram weight gain was about 10% less for fish fed diet COPF‐60 than for diet COPF‐0. Percentages of saturated fatty acids in dietary and fillet lipids varied narrowly. Moreover, percentages of 18:1n‐9, monounsaturated fatty acids, 18:2n‐6, n‐6 fatty acids, 18:3n‐3, and ratios of n‐6 to n‐3 fatty acids in the flesh lipids were directly related to the dietary level of CO and PF whereas 22:6n‐3, the total of 20:5n‐3 (eicosapentaenoic acid; EPA) and 22:6n‐3 (docosahexaenoic acid; DHA), and n‐3 fatty acids revealed the opposite trend. Percentages of 22:6n‐3, EPA and DHA, and n‐3 fatty acids were significantly depressed in fish fed diet COPF‐60 versus diet COPF‐0. We conclude that a 1:1 blend of CO and PF is an excellent cost‐effective dietary source of supplemental lipid for Atlantic salmon in sea water.     

Effects of various dietary factors on astaxanthin absorption in Atlantic salmon (Salmo salar)

The experiment was designed to investigate the dietary factors that might enhance or interfere with astaxanthin (Ax) absorption in salmon including potentially interfering factors such as certain carotenoids (zeaxanthin and lutein), plant sterols, fibre and enhancing compounds such as cholesterol and vitamin E. Two hundred and eighty‐eight salmon (778 ± 78 g) were reared in sea water under controlled conditions and fed practical experimental diets. The experimental diets were supplemented with 40 mg Ax kg^?1, in addition to various dietary factors, including cholesterol (2%), vitamin E (450 IU kg^?1), wheat bran (5%), lutein (40 mg kg^?1), zeaxanthin (40 mg kg^?1) and phytosterol (2%). After 26 days of feeding, blood was collected and plasma was separated to determine the plasma Ax concentration. Ax was not detected in the plasma of fish fed the non‐pigmented diet. Fish fed diet containing 2% cholesterol significantly improved Ax absorption, which was reflected in the higher Ax concentration in plasma of Atlantic salmon. Other supplements including vitamin E, wheat bran, lutein, zeaxanthin and phytosterols in diet had no significant effect on plasma Ax concentration . Fish fed diet containing 2% cholesterol significantly increased cholesterol concentration in fish plasma. Phytosterol had no benefit to lower cholesterol plasma level in fish fed 2% phytosterol‐supplemented diet.